[1] |
SHEN Chang, AI Kelong, HU Changping.
Research progress in the regulation of hypoxic pulmonary hypertension by hypoxia-inducible factor-1 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 114-120.
|
[2] |
NIU Pilian, FAN Yongxin, LU Furui, ZHOU Xuezhang, BAI Mingsheng.
Effects of liquorice extract on cardiac fibroblasts fibrosis induced by TGF-β1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 129-135.
|
[3] |
ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong.
Molecular mechanism and treatment of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
|
[4] |
LU Ruibin, ZHAO Hui, XIE Qiuling, HU Lu, GUO Chaowan, PEI Yunlin, XIONG Sheng.
Anti-FGF-2 nanobody inhibits rat corneal angiogenesis induced by alkali burn
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 609-615.
|
[5] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[6] |
XIE Rongrong, CHEN Zhi, YANG Yu, XIE Raoying, LI Pingping, SUN Shuangshuang, CHEN Wenjun.
Treatment strategies of FGFR molecular alterations in lung squamous cell carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 196-203.
|
[7] |
ZHOU Xiaohong, SHENG Yongjia, GU Yanling, WANG Jin.
NADPH oxidase NOX4 inhibitor regulates the formation and mechanism of hepatoma related fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 976-983.
|
[8] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|
[9] |
GU Yanling, SHENG Yongjia, WANG Jin.
Polysaccharide inhibits tumor associated fibroblasts transformation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 266-271.
|
[10] |
JIN Hui, ZHOU Ziye, LIANG Jing, WANG Chenxiang, SONG Lintao, ZHAO Longwei, GUO Kaiwen.
Research progress of fibroblast growth factor 1 in the treatment of diabetes and related diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 111-115.
|
[11] |
CHEN Yonghua, CAO Qunfen, HONG Qiongyi, WANG Shumin.
Effect of tenofovir disoproxil fumarate on serum FGF-23,β2-MG,Cys-C and RBP level in patients with chronic hepatitis B
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 799-804.
|
[12] |
CHEN Yan, YE Bin, MOU Wen-yuan, YU Cheng-bo, LIN Bu, YIN Xiang-peng, XU Hong-miao.
Effect of anti-tumor necrosis factor antibody on TRAIL and TNF-α expression induced by lipopolysaccharide in human periodontal ligament fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 493-498.
|
[13] |
HE Sheng-hu, ZHOU Sheng-hua, ZHANG Jing, WANG Xue-fei, WANG Da-xin.
Effect of human umbilical vein endothelial cells apoptosis induced by ethanol and the expression of ICAM-1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 266-268.
|
[14] |
WANG Xin, WANG De-guo, ZHAO Chun-mei, XING Wen, WANG An-cai, ZHU Hong-jun, SUN Xian-lin.
The effects of TGFβ1 on the expression of α-SMA and Cx43 in cultured cardiac fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 738-742.
|
[15] |
ZHANG Min, CAO Shu-ren.
Effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1081-1086.
|